Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,419 | -17,426 | -25,002 | -17,803 | -18,260 |
| Depreciation Amortization | 76,543 | 38,283 | 138,939 | 95,835 | 57,795 |
| Income taxes - deferred | -682 | -46 | -8,391 | -7,313 | -9,410 |
| Accounts receivable | 15,640 | 3,993 | -21,780 | -34,063 | -36,165 |
| Accounts payable and accrued liabilities | -1,075 | -502 | -707 | 3,436 | 2,426 |
| Other Working Capital | 15,005 | -24,861 | -12,713 | -36,261 | -30,680 |
| Other Operating Activity | 26,381 | 28,230 | 53,884 | 54,074 | 49,430 |
| Operating Cash Flow | $127,393 | $27,671 | $124,230 | $57,905 | $15,136 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -232 | -176 | -1,622 | -682 | -569 |
| Net Acquisitions | N/A | N/A | -572,069 | -572,069 | -572,069 |
| Purchase Of Investment | -41,661 | 0 | N/A | 0 | N/A |
| Investing Cash Flow | $-41,893 | $-176 | $-573,691 | $-572,751 | $-572,638 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 235,220 | 235,654 | 517,682 | 517,682 | 517,682 |
| Debt Repayment | -209,471 | -163,638 | -75,000 | -50,000 | -25,000 |
| Common Stock Issued | 5,268 | 4,017 | 12,148 | 5,285 | 5,009 |
| Common Stock Repurchased | N/A | N/A | -14,063 | -6,422 | N/A |
| Other Financing Activity | -7,956 | -7,736 | -4,044 | -3,999 | -3,893 |
| Financing Cash Flow | $23,061 | $68,297 | $436,723 | $462,546 | $493,798 |
| Beginning Cash Position | 176,235 | 176,235 | 188,973 | 188,973 | 188,973 |
| End Cash Position | 284,796 | 272,027 | 176,235 | 136,673 | 125,269 |
| Net Cash Flow | $108,561 | $95,792 | $-12,738 | $-52,300 | $-63,704 |
| Free Cash Flow | |||||
| Operating Cash Flow | 127,393 | 27,671 | 124,230 | 57,905 | 15,136 |
| Capital Expenditure | -232 | -176 | -1,622 | -682 | -569 |
| Free Cash Flow | 127,161 | 27,495 | 122,608 | 57,223 | 14,567 |